JNJ vs. MDT

In the year-to-date period, JNJ achieves a 8.28% return, which is significantly higher than MDT's 6.04% return. Over the past 10 years, JNJ has outperformed MDT with an annualized return of 7.45%, while MDT has yielded a comparatively lower 3.65% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Johnson & Johnson (JNJ) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current JNJ Sharpe Ratio is 0.42, which is comparable to the MDT Sharpe Ratio of 0.38. The chart below compares the historical Sharpe Ratios of JNJ and MDT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

JNJ's dividend yield for the trailing twelve months is around 3.19%, less than MDT's 3.33% yield.

The maximum JNJ drawdown since its inception was -52.60%, smaller than the maximum MDT drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for JNJ and MDT. For additional features, visit the drawdowns tool.

Johnson & Johnson (JNJ) has a higher volatility of 10.85% compared to Medtronic plc (MDT) at 9.54%. This indicates that JNJ's price experiences larger fluctuations and is considered to be riskier than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Johnson & Johnson and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.